Summary
Updated Aug 31, 2026
Jesse Goodman files SEC Form 4 reports at Intellia Therapeutics, Inc. (NTLA). 2 SEC Form 4 filings on record going back to 2025, most recently on 10 June 2026. Most recent open-market trade: sold $14K of NTLA on 30 June 2025. Lifetime open-market sales: $29K.
Recent Transactions
3Every recent SEC Form 4 transaction Jesse Goodman has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Jesse Goodman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- John M. Leonard - $1.44M of NTLA open-market activity in the last 12 months
- Fred E. Cohen - $1.40M of NTLA open-market activity in the last 12 months
- Edward J. Dulac III - $234K of NTLA open-market activity in the last 12 months
- James Basta - $112K of NTLA open-market activity in the last 12 months
- David Lebwohl - $110K of NTLA open-market activity in the last 12 months
- Michael P. Dube - $104K of NTLA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Jesse Goodman?
Jesse Goodman is a corporate insider of Intellia Therapeutics, Inc. (NTLA). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jesse Goodman submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Jesse Goodman been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($29K) across all tracked filings.
Where can I see all of Jesse Goodman's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Jesse Goodman and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
